What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Psychiatry
Jari Haukka spends much of his time researching Psychiatry, Internal medicine, Cohort study, Pediatrics and Schizophrenia.
Jari Haukka interconnects Proportional hazards model, Suicide prevention and Risk factor in the investigation of issues within Psychiatry.
The study incorporates disciplines such as Major depressive disorder, Depression and Injury prevention in addition to Suicide prevention.
His work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Surgery.
His study in Cohort study is interdisciplinary in nature, drawing from both Borderline intellectual functioning, Intellectual ability, Clinical psychology, Prospective cohort study and Mean age.
His Schizophrenia study integrates concerns from other disciplines, such as Audiology, Visual memory, Working memory, Psychosis and Developmental psychology.
His most cited work include:
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). (880 citations)
- Completed Suicide After a Suicide Attempt: A 37-Year Follow-Up Study (463 citations)
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia (405 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Psychiatry, Cohort study, Cohort and Population study.
His Internal medicine study focuses on Incidence in particular.
His Psychiatry research integrates issues from Suicide prevention and Risk factor.
His Cohort study study combines topics from a wide range of disciplines, such as Mortality rate and Poisson regression.
The Population study study combines topics in areas such as Statin and Medical prescription.
His research investigates the connection with Schizophrenia and areas like Pediatrics which intersect with concerns in Hazard ratio.
He most often published in these fields:
- Internal medicine (42.29%)
- Psychiatry (30.05%)
- Cohort study (15.69%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (42.29%)
- Cohort study (15.69%)
- Population study (15.16%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Cohort study, Population study, Mortality rate and Observational study.
His research integrates issues of Diabetes mellitus and Injection therapy in his study of Internal medicine.
He has researched Cohort study in several fields, including Statin, Statin treatment, Poisson regression and Cause of death.
In his study, which falls under the umbrella issue of Poisson regression, Cohort, Retrospective cohort study, Body mass index and Disease is strongly linked to Obstetrics.
His studies in Population study integrate themes in fields like Periodontitis, CYP2C19, Citalopram, Depression and Risk factor.
His study on Observational study also encompasses disciplines like
- Insulin which intersects with area such as Stroke and Medical prescription,
- Relative risk that intertwine with fields like Confounding, Hazard ratio and Outcome.
Between 2018 and 2021, his most popular works were:
- Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial (6 citations)
- Completed suicides of citalopram users-the role of CYP genotypes and adverse drug interactions. (5 citations)
- Active Matrix Metalloproteinase-8 Chair Side Mouth Rinse Test, Health Behaviour and Oral Health in Finnish Adolescent Cohort (4 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
